| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/18/2001 | DE19932688A1 Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften Design of beta-sheet proteins with specific binding properties |
| 01/18/2001 | DE19930676A1 Verfahren zur Stabilisierung von Proteinen in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A process for the stabilization of proteins in complex mixtures with storage thereof in aqueous solvents |
| 01/18/2001 | CA2680437A1 Peptides that lower blood glucose levels |
| 01/18/2001 | CA2385102A1 Expression vectors and methods |
| 01/18/2001 | CA2381125A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | CA2379373A1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and .beta.1 integrins |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378985A1 Atherosclerosis-associated genes |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378485A1 Proliferation differentiation factor |
| 01/18/2001 | CA2378452A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | CA2378451A1 Anti-idiotypic antibodies of fibroblast growth factors and their use as medicines |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2378097A1 Induction of a th1-like response in vitro |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/17/2001 | EP1069185A1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody |
| 01/17/2001 | EP1069182A1 Alleviation of symptoms associated with inflammatory disease states, using antibodies to CD18 |
| 01/17/2001 | EP1069136A1 Method for the recombinant production of ribonucleoproteins |
| 01/17/2001 | EP1068522A1 Antigen |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068348A1 Method of preparing polypeptides in cell-free system and device for its realization |
| 01/17/2001 | EP1068336A2 Membranemetalloprotease nepii |
| 01/17/2001 | EP1068329A2 FUSION PROTEINS OF $i(MYCOBACTERIUM TUBERCULOSIS) ANTIGENS AND THEIR USES |
| 01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
| 01/17/2001 | EP1068323A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/17/2001 | EP1068322A1 U4, a member of the hematopoietin receptor superfamily |
| 01/17/2001 | EP1068318A2 Human nucleic acid sequences from prostate tissue |
| 01/17/2001 | EP1068317A2 Human nucleic acid sequences from prostate tumour tissue |
| 01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
| 01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068301A2 Bacterial transglutaminases |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
| 01/17/2001 | EP1068237A1 T cell receptor expression cassette |
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068235A1 G-protein coupled receptors |
| 01/17/2001 | EP1068226A1 Lipopeptides inducing t lymphocytic cytotoxicity bearing at least one auxiliary t epitope, and uses for vaccination |
| 01/17/2001 | EP1068223A1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 01/17/2001 | EP1068220A1 nrdF |
| 01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
| 01/17/2001 | EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 01/17/2001 | EP1067940A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 01/17/2001 | EP0640135B1 Immunoglobulin binding proteins derived from l protein and their uses |
| 01/17/2001 | EP0589982B1 Monoclonal antibodies against human tnf-binding protein i (tnf-bp i) |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280615A Expression of endogenous genes by non-homologons recombination of a vactor construct with cellular DNA |
| 01/17/2001 | CN1280586A Erythropoietin with high specific activity |
| 01/17/2001 | CN1280501A Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/17/2001 | CN1280191A Method for producing nucleic acid inhibiting albumen by inducing and cultivating trichoid root of chinese trichosanthes |
| 01/16/2001 | US6175060 Transgenic plant having a cell transformed by a vector including dna which activates transcription of a structural gene under conditions of phosphate-starvation; recombinant production of proteins; disease resistance |
| 01/16/2001 | US6174997 Antibody which specifically binds polypeptide of defined amino acid sequence; diagnosis of non-hodgkin's lymphoma; anticarcinogenic agents |
| 01/16/2001 | US6174995 Amino acid sequences of chemokine beta-4 and monocyte chemotactic protein-4; anticarcinogenic/antitumor agents; antifibrotic/antiarthritic/antiinflammatory agents; treatment of chronic infections, autoimmune disorders, psoriasis |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174723 Cocaine derivative, protein conjugate thereof, monoclonal antibody producing cell line, method for preparing the cell line and monoclonal antibody |
| 01/16/2001 | US6174721 Protein having kunitz-type domains of tissue factor pathway inhibitors and lacking glycosylation sites; for prevention and treatment of septic shock |
| 01/16/2001 | US6174717 Elicitor of the hypersensitive response in plants |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174692 Detecting preferential antigen in sample; incubating monoclonal antibody with sample containing preferential antigen and detecting biinding |
| 01/16/2001 | US6174691 Deactivating a preferential tumor glycoprotein or a cell expressing preferential glycoprotein; exposing preferential glycoprotein or cell expressing the preferential glycoprotein to a toxic substance |
| 01/16/2001 | US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/16/2001 | US6174674 Detecting nucleotide sequence adjustment; hybridizing centromeric probe to human sample, hybridizing second teleomeric probe to human sample, detecting centromeric and telomeric hybridization positioning |
| 01/16/2001 | US6174532 L2 immunogenic peptides of papillomavirus |
| 01/16/2001 | US6174513 A storage stable therapeutic composition comprising one or more surfactants to prevent radiolysis during storage; producing therapeutic effects on targeted tissues |
| 01/16/2001 | CA2204355C Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/16/2001 | CA2093659C Dna sequence encoding bovine .alpha.-lactalbumin and methods of use |
| 01/16/2001 | CA2076979C Substantially pure transforming growth factor-.beta.-1-binding protein and nucleotide sequences expressing the binding protein |
| 01/16/2001 | CA1341172C Synthetic insecticidal crystal protein gene |
| 01/16/2001 | CA1341170C Calcium channel compositions and methods |
| 01/16/2001 | CA1341169C Factor viii analog, process for its preparation and composition containing it |
| 01/16/2001 | CA1341166C Antigenic proteins and vaccines containing them for prevention of coccidiosis |
| 01/11/2001 | WO2001002607A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | WO2001002594A2 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER |
| 01/11/2001 | WO2001002588A2 Generation of specific binding partners binding to (poly)peptides encoded by genomic dna fragments or ests |
| 01/11/2001 | WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | WO2001002586A1 Human alpha 1,2-mannosidase |
| 01/11/2001 | WO2001002585A1 Gene encoding cyclic lipopeptide acylase and expression of the same |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002565A2 Secreted protein zacrp4 |
| 01/11/2001 | WO2001002561A2 Mammalian calcium channels and related probes, cell lines and methods |
| 01/11/2001 | WO2001002560A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 01/11/2001 | WO2001002440A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 01/11/2001 | WO2001002435A1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000053748A3 Casb618 polynucleotides and polypeptides and their use |
| 01/11/2001 | WO2000047622A3 Peptides with anti-angiogenic activity |
| 01/11/2001 | WO2000029561A8 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |
| 01/11/2001 | DE19931883A1 DNA kodierend für Beta-Tubulin und deren Verwendung DNA coding for beta-tubulin, and the use thereof |
| 01/11/2001 | DE19931380A1 Verfahren zur rekombinanten Herstellung von Ribonukleoproteinen A method for the recombinant production of ribonucleoproteins |
| 01/11/2001 | DE19929887A1 cDNA-Sequenzen von zwei Interakoren FANCIP2 und FANCIP3 des Fanconi-Anämie-Proteins der Komplementationsgruppe A cDNA sequences of two Interakoren FANCIP2 and FANCIP3 of the Fanconi anemia complementation group A-protein of the |
| 01/11/2001 | CA2590625A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phospho-transferase system proteins |
| 01/11/2001 | CA2590403A1 Corynebacterium glutamicum genes encoding phosphoenolpyruvate:sugar phospho-transferase system proteins |
| 01/11/2001 | CA2378951A1 Secreted protein zacrp4 |
| 01/11/2001 | CA2378539A1 Adenovirus carrying gag gene hiv vaccine |